The safety and efficacy of isradipine as well as its long-term effects on renal hemodynamics
were evaluated in a study of 17 patients with mild-to-moderate essential hypertension and …

The long-term hemodynamic and antihypertensive effects of isradipine were investigated in
11 patients who had normal renal function and 9 who had reduced renal function. The dose …

The objective of this double-blind, placebo-controlled study was to evaluate the effects of
isradipine on renal hemodynamics and function. Ten patients with mild-to-moderate …

The hemodynamic and renal effects of isradipine were investigated in 10 hypertensive
patients treated for 3.5 months and in a further nine patients treated for two years. Both …

The antihypertensive, humoral, and renal effects of acute single oral administration of
placebo and isradipine, a new dihydropyridine calcium antagonist, at doses of 2.5 mg, 5.0 …

The immediate and short-term cardiovascular effects of oral isradipine therapy were
evaluated in 11 patients with mild to moderate systemic hypertension. Isradipine, 5 mg …

Twenty-three men with essential hypertension participated in a double-blind placebo-
controlled study with a crossover design to evaluate the long-term (nine weeks) effects of …

Isradipine, 2.5 mg twice daily and placebo were administered for 4 weeks to 11 untreated
essential hypertensives in a double-blind, random order, crossover study. At the end of each …

After a placebo run-in phase of four weeks' duration, 1.25 mg or 2.5 mg isradipine twice daily
orally was administered for one year to 23 patients who had been diagnosed as …

One hundred seventy-eight patients, aged 30 to 85, with mild-to-moderate hypertension
entered a multicenter double-blind, randomized, between-patient comparison of isradipine …